June 4, 2014

Many cancer treatments are extraordinarily expensive. Some drugs can cost up to a hundred thousand dollars a year and those costs can go up as much as 15% annually. But, new research is taking a second look at profitable prescriptions, and whether increasing access to care may be better for health providers’ bottom lines in the long run. Chuck Coppola reports.

Additional Clips

  • Weak Job Churn 8-1-14

    August 1, 2014

    Bill Moller talks with employment recruiter Scott Sargis about the low churn of jobs as the economy improves.

  • Chart Talk 8-1-14

    August 1, 2014

    Dan Stecich of Athena Advisory Services has an eye on Lumber Liquidators after falling earnings.

  • Trader Talk 8-1-14

    August 1, 2014

    Bob Iaccino of Tethys Partners looks at the dip in stocks and long-tern results.

  • Workplace Shooting 8-1-14

    August 1, 2014

    A shooting over layoffs in a downtown Chicago office brings up questions of workplace violence and safety. Chuck Coppola reports.

  • Traders Unplugged 8-1-14

    August 1, 2014

    Alan Knuckman and Scott Shellady get in the ring to talk Twitter earnings and the future of social media stocks.

  • 8-1-14 FULL EPISODE

    August 1, 2014

    Financial news, analysis, and today’s investment ideas.

  • As Chicago Goes… 7-31-14

    July 31, 2014

    Steve Trepiccione, a Senior VP for HSBC Bank looks at how Chicago grew to be a main manufacturing hub, and what other cities can do to follow in its footsteps.

  • Movies & Money 7-31-14

    July 31, 2014

    Erik Childress of the Chicago Film Critics Association says get ready for Marvel mania.

  • Chart Talk 7-31-14

    July 31, 2014

    Matt Cavanaugh of CMZ Trading says Tesla is the wild card in the market today.

  • Inversion Backlash 7-31-14

    July 31, 2014

    Diane Moca reports as lawmakers try and put an end to a popular corporate tax maneuver.